NEW YORK (GenomeWeb) – The Broad Institute has granted GE Healthcare and Sigma-Aldrich non-exclusive licenses to intellectual property covering CRISPR/Cas9 for research applications, the companies announced separately today.

Under the arrangements, both companies will have access to the CRISPR IP portfolio, which includes patents related to the use of the gene-editing technology in eukaryotic cells that was pioneered in the lab of Broad researcher Feng Zhang.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.